BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Conditions
Solid Tumor Cancer · Locally Advanced · Metastatic Solid Tumors · Urothelial Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Avenzo Therapeutics Recruiting Site, San Francisco, California, United States
Avenzo Therapeutics Recruiting Site, Aurora, Colorado, United States
Avenzo Therapeutics Recruiting Site, Orlando, Florida, United States
Avenzo Therapeutics Recruiting Site, Tampa, Florida, United States
Avenzo Therapeutics Recruiting Site, Boston, Massachusetts, United States
Avenzo Therapeutics Recruiting Site, New York, New York, United States
Avenzo Therapeutics Recruiting Site, Chapel Hill, North Carolina, United States
Avenzo Therapeutics Recruiting Site, Myrtle Beach, South Carolina, United States
Avenzo Therapeutics Recruiting Site, Nashville, Tennessee, United States
Avenzo Therapeutics Recruiting Site, Austin, Texas, United States
Avenzo Therapeutics Recruiting Site, Irving, Texas, United States